Daniil Rotin

Daniil Rotin

Auto-generated profile, based on publicly available information

Daniil Rotin

Moscow Clinical Research and Practical Center, Moscow Healthcare Department, Moscow, Russia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Science
Verified
Journal Article
Closed access
PDF file
EBErez N. Baruch
Erez N. Baruch
IYIlan Youngster
Ilan Youngster
GBGuy Ben-Betzalel
Guy Ben-Betzalel
RORona Ortenberg
Rona Ortenberg
ALAdi Lahat
Adi Lahat
BBBen Boursi
Ben Boursi
New fecal microbiota for cancer patients: The composition of the gut microbiome influences the response of cancer patients to immunotherapies. Baruch et al. and Davar et al. report first-in-human clinical trials to test whether fecal microbiota transplantation (FMT) can affect how metastatic melanoma patients respond to anti–PD-1 immunotherapy (see the Perspective by Woelk and Snyder). Both studies observed evidence of clinical benefit in a subset of treated patients. This included increased abundance of taxa previously shown to be associated with response to anti–PD-1, increased CD8 + T cell activation, and decreased frequency of interleukin-8–expressing myeloid cells, which are involved in immunosuppression. These studies provide proof-of-concept evidence for the ability of FMT to affect immunotherapy response in cancer patients. Science , this issue p. 602 , p. 595 ; see also p. 573

15 March 2017 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
APA I Parfenov
A I Parfenov
SBS V Bykova
S V Bykova
ESE A Sabel'Nikova
E A Sabel'Nikova
IMI V Maev
I V Maev
ABA A Baranov
A A Baranov
LEL I Efremov
L I Efremov
1Moscow Clinical Research-and-Practical Center, Moscow Healthcare Department, Moscow; 2A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow; 3Children’s Health Research Center, Ministry of Health of Russia, Moscow; 4I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia, Saint Petersburg; 5M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow; 6Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow; 7Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk; 8Russian Children’s Clinical Hospital, Moscow; 9Department of Pediatrics, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow; 10I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg; 11Acad. Yu.E. Veltishchev Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 12Clinic Four, Department of Pediatrics, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg; 13Childhood Diseases Department Two, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 14Research Laboratory of Surgical Gastroenterology and Endoscopy, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 15Department of Endoscopic Surgery, City Clinical Hospital Thirty-One, Moscow Healthcare Department, Moscow; 16A.N. Ryzhikh State Research Center of Coloproctology, Ministry of Health of Russia, Moscow; 17Department of Intermediate-Level Therapy, Tver State Medical University, Ministry of Health of Russia, Tver; 18Laboratory of Medical Genetics, Diagnostic Center of Medical Genetics, Saint Petersburg; 19HLA Typing Laboratory, Blood Transfusion Station, Moscow Healthcare Department, Moscow; 20S.P. Botkin City Clinical Hospital, Moscow Healthcare Department, Moscow; 21Department of Nervous System Diseases, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow; 22Department of Endocrinology and Diabetology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow; 23Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow; 24Department of Therapy, Kazan State Medical Academy, Ministry of Health of Russia, Kazan; 25Department of Intermediate-Level Therapy with Course of Occupational Diseases, Faculty of General Medicine, Omsk State Medical University, Ministry of Health of Russia, Omsk; 26Dmitry Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Health of Russia, Moscow The paper presents the All-Russian consensus on the diagnosis and treatment of celiac disease in children and adults, which has been elaborated by leading experts, such as gastroenterologists and pediatricians of Russia on the basis of the existing Russian and international guidelines. The consensus approved at the 42nd Annual Scientific Session of the Central Research Institute of Gastroenterology on Principles of Evidence-Based Medicine into Clinical Practice (March 2—3, 2016). The consensus is intended for practitioners engaged in the management and treatment of patients with celiac disease. Evidence for the main provisions of the consensus was sought in electronic databases. In making recommendations, the main source was the publications included in the Cochrane Library, EMBASE, MEDLINE, and PubMed. The search depth was 10 years. Recommendations in the preliminary version were reviewed by independent experts. Voting was done by the Delphic polling system.

1 November 2004 in Doklady Biological Sciences
Verified
Journal Article
Closed access
PDF file
ALA. A. Lushnikova
A. A. Lushnikova
IKI. N. Kryukova
I. N. Kryukova
DRD. L. Rotin
D. L. Rotin
LLL. N. Lubchenko
L. N. Lubchenko

15 February 2017 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
IBI G Bakulin
I G Bakulin
YSYu G Sandler
Yu G Sandler
EVE V Vinnitskaya
E V Vinnitskaya
VKV A Keiyan
V A Keiyan
SRS V Rodionova
S V Rodionova
DRD L Rotin
D L Rotin
Medical article медицинская статья

1 January 2016 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
LAL. I. Astaf’eVa
L. I. Astaf’eVa
BKB. A. Kadashev
B. A. Kadashev
LSL. V. Shishkina
L. V. Shishkina
PKP. L. Kalinin
P. L. Kalinin
DFD. V. Fomichev
D. V. Fomichev
DRD. L. Rotin
D. L. Rotin
Medical article медицинская статья

1 January 2016 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
NMNadia Mazerkina
Nadia Mazerkina
YTYuri Trunin
Yuri Trunin
SGSergey Gorelyshev
Sergey Gorelyshev
AGAndrey Golanov
Andrey Golanov
BKBoris Kadashev
Boris Kadashev
EOElizabet Orlova
Elizabet Orlova
Thyrotropinomas (TSHomas) are rare pituitary adenomas, particularly in childhood. We present here the case of an 11-year-old boy with type 1 autoimmune polyglandular syndrome (APS1) and TSHoma which was diagnosed by elevated thyroid – stimulating hormone and thyroid hormones levels without evident clinical signs of hyperthyroidism. He was underwent partial resection of the tumor via transsphenoidal approach and subsequently radiation therapy. Consequently, 1 year after radiotherapy, the patient developed growth hormone deficiency, three and half years after radiation became euthyroid, and five and half years after treatment – hypothyroid. This is the first case of the coexistence of these two rare endocrine diseases in one patient.